Figure 4: A decrease in insulin-like growth factor type-I could be noticed from 1 day until 1 week after the intravenous allogenic mesenchymal stem cell (MSC) injection (T1-2). The narrow lines represent the different individuals, whereas the thick lines represent the average values.